🎯 Options Strategy & Quant Allocation
【Strategy 1: Bull Call Spread (Debit Spread)】
- Underlying: $Kiniksa Pharmaceuticals Ltd.(KNSA)$
- View: Cautiously Bullish (Short-term consolidation after breakout, targeting a move towards the $55-$62 analyst range).
- Strategy Type: Debit Spread / Directional Bullish
- Option Contract Portfolio:
- Buy 1 KNSA 18 Jun 2026 $55 Call @ ~$3.525
- Sell 1 KNSA 18 Jun 2026 $60 Call @ ~$2.025
- Max Gain & Loss: Max Gain = $5.00 - $1.50 = $3.50 per spread. Max Loss = Net Debit Paid = $1.50 per spread.
- Initial Cost/Credit: Net Debit = ~$1.50
- Greek Exposure (Simulated):
- Delta: +0.173 (Positive, moderate directional exposure to upside)
- Theta: +0.002 (Slightly positive, time decay is neutral to slightly beneficial)
- Vega: +0.006 (Slightly positive, benefits from a small IV increase)
- Gamma: -0.006 (Low, as the spread is long Gamma near short strike)
- Rho: +0.011 (Low positive, benefits slightly from rising rates)
- Rationale: This strategy is optimal for a cautiously bullish view following a massive breakout with elevated IV (72.79% IV, 94.82% IV Percentile). The bull call spread limits capital at risk (defined max loss) while allowing participation in a continued move towards $60. It is a Vega-positive spread, which is advantageous as the high IV may compress if the stock consolidates, but we still gain if IV rises further. The Theta is near-neutral, mitigating the heavy decay risk of a long call in a high-IV environment. Profit is maximized if KNSA closes at or above $60 at expiration.
- Time Frame: Short to Medium Term (June 18, 2026 expiry).
😍 Been eyeing Tiger merch but short on Tiger Coins? Now's your chance.
🎁 We’ve selected 4 high-demand items across practial, lifestyle, and learning, now with a lower redemption threshold!
Hot Merch Returns · Up to 43% Off
Comments